Investing in shrink-labels and PVC production capabilities will boost Klöckner’s ability to provide pharma clients with a range of products, including tamper evident closures and barrier-enhanced films.
“These expansions will enable us to continue to support our customers’ growing global demand for high-quality packaging films”, added Tom Goeke, CEO of the Klöckner Pentaplast Group.
PVC film production machinery is being installed at Klöckner’s manufacturing facility in Rayong, Thailand. Klöckner expects the new production line to be operational by early 2011 and to add 12,500 tons of capacity.
The production line is designed to meet the requirements and regulatory standards of the pharma industry. Klöckner claims it is the only local producer in Asia to meet these manufacturing standards.
Products in Klöckner’s range of pharmaceutical packaging films range from mono films to high-performance barrier-enhanced films and have applications in clinical, ethical, compliance and blister display.
Shrink-label expansion
Klöckner is also adding shrink-label film capacity at its manufacturing facilities in Rayong and Rural Retreat, Virginia, US. A tentering line will be added at both sites to increase capacity for high-performance PETG and PVC shrink films.
The company is aiming to start production in early 2011 and expects that when operational the new lines will add 15,000 tons of shrink-film capacity.
Klöckner’s product range includes transverse-direction orientated (TDO) and machine-direction orientated (MDO) shrink films that have a variety of applications, including tamper evident closures.
The expansions are expected to add 64 employees worldwide.